Long noncoding RNA ZNF667‐AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA‐93‐3p‐dependent PEG3 downregulation

Yong‐Jie Li,Zhe Yang,Yi‐Ying Wang,Yue Wang
DOI: https://doi.org/10.1002/1878-0261.12565
2019-10-17
Molecular Oncology
Abstract:<p>Zinc finger protein 667‐antisense RNA 1 (ZNF667‐AS1), located on human chromosome 19q13.43, is a member of the C2H2 zinc finger protein family. Herein, we aimed to analyze the interactions between ZNF667‐AS1, microRNA‐93‐3p (miR‐93‐3p), and paternally expressed gene 3 (PEG3), and to explore their roles in the tumorigenesis of cervical cancer (CC). Differentially expressed lncRNAs and miRNAs related to CC were determined using gene‐expression datasets sourced from the GEO database. Subsequently, the regulatory relationships between ZNF667‐AS1 and miR‐93‐3p and between miR‐93‐3p and PEG3 were identified using the dual luciferase reporter gene assay. In addition, the expression of miR‐93‐3p and ZNF667‐AS1 was up‐ or down‐regulated in CC cells (HeLa), in order to assess their effects on cell cycle distribution and cell invasion <i>in vitro</i>, and tumor growth and metastasis <i>in vivo</i>. MiR‐93‐3p was found to be highly expressed while ZNF667‐AS1 and PEG3 were poorly expressed in CC. ZNF667‐AS1 could competitively bind to miR‐93‐3p, which targeted PEG3. In addition, miR‐93‐3p down‐regulation and ZNF667‐AS1 overexpression led to increased expression of PEG3, TIMP‐2 and p16, and decreased expression of Cyclin D1, MMP‐2, and MMP‐9. MiR‐93‐3p inhibition and ZNF667‐AS1 elevation also inhibited cell cycle entry and cell invasion <i>in vitro</i>, but repressed tumor growth and metastasis <i>in vivo</i>. These key findings demonstrated that upregulation of ZNF667‐AS1 could suppress the progression of CC <i>via</i> the modulation of miR‐93‐3p‐dependent PEG3, suggesting a potential therapeutic target for the treatment of CC.</p>
oncology
What problem does this paper attempt to address?